These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35213388)

  • 1. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.
    Negrini M; Tomasello G; Davidsson M; Fenyi A; Adant C; Hauser S; Espa E; Gubinelli F; Manfredsson FP; Melki R; Heuer A
    J Parkinsons Dis; 2022; 12(4):1133-1153. PubMed ID: 35213388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
    Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
    J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
    Boutros SW; Raber J; Unni VK
    J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular injection of α-synuclein preformed fibrils do not induce motor and olfactory impairment in C57BL/6 mice.
    Mi X; Li M; Zhang Y; Qu L; Xu A; Xie J; Song N
    Neuroscience; 2024 Nov; 559():293-301. PubMed ID: 39251058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests.
    Gubinelli F; Cazzolla G; Negrini M; Kulacz I; Mehrdadian A; Tomasello G; Venuti C; Sarauskyte L; Jacobs F; Manfredsson FP; Davidsson M; Heuer A
    Behav Brain Res; 2022 Jul; 429():113887. PubMed ID: 35405174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
    Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
    Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
    Morales-Prieto N; Bevans R; O'Mahony A; Barron A; Giles Doran C; McCarthy E; Concannon RM; Goulding SR; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
    Aging Cell; 2024 Jun; 23(6):e14155. PubMed ID: 38529808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody.
    Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y
    J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
    Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
    Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
    Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
    Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
    Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
    Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcellular propagation of fibrillar α-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent.
    Rodrigues PV; de Godoy JVP; Bosque BP; Amorim Neto DP; Tostes K; Palameta S; Garcia-Rosa S; Tonoli CCC; de Carvalho HF; de Castro Fonseca M
    Sci Rep; 2022 Mar; 12(1):4168. PubMed ID: 35264710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
    Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
    Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain.
    Delenclos M; Faroqi AH; Yue M; Kurti A; Castanedes-Casey M; Rousseau L; Phillips V; Dickson DW; Fryer JD; McLean PJ
    Acta Neuropathol Commun; 2017 Jun; 5(1):51. PubMed ID: 28645308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
    Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T
    Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss.
    Guo Q; Kawahata I; Jia W; Wang H; Cheng A; Yabuki Y; Shioda N; Fukunaga K
    CNS Neurosci Ther; 2023 Jun; 29(6):1547-1560. PubMed ID: 36786129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils.
    Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P
    J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression.
    Höfs L; Geißler-Lösch D; Wunderlich KM; Szegö EM; Van den Haute C; Baekelandt V; Hoyer W; Falkenburger BH
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.
    Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J
    Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.